1390658-91-9

Basic information

• Product Name: tert-butyl 4-(4-((2-(2,5-difluorobenzyl)-5-oxo-5,6-dihydropyrido[2,3-d]pyridazin-4-yl)amino)-3-methoxyphenyl)piperidine-1-carboxylate
• Synonyms: tert-butyl 4-(4-((2-(2,5-difluorobenzyl)-5-oxo-5,6-dihydropyrido[2,3-d]pyridazin-4-yl)amino)-3-methoxyphenyl)piperidine-1-carboxylate
• CAS NO: 1390658-91-9
• Molecular Weight: 577.631
• Mol File: 1390658-91-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: tert-butyl 4-(4-((2-(2,5-difluorobenzyl)-5-oxo-5,6-dihydropyrido[2,3-d]pyridazin-4-yl)amino)-3-methoxyphenyl)piperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-(4-((2-(2,5-difluorobenzyl)-5-oxo-5,6-dihydropyrido[2,3-d]pyridazin-4-yl)amino)-3-methoxyphenyl)piperidine-1-carboxylate(1390658-91-9)
• EPA Substance Registry System: tert-butyl 4-(4-((2-(2,5-difluorobenzyl)-5-oxo-5,6-dihydropyrido[2,3-d]pyridazin-4-yl)amino)-3-methoxyphenyl)piperidine-1-carboxylate(1390658-91-9)

Safety Data

• Hazardous Substances Data: 1390658-91-9(Hazardous Substances Data)

Upstream product

• 59557-91-4 4-bromo-2-methoxyaniline 
• 1390657-40-5 2,4-dichloropyrido[2,3-d]pyridazin-5(6H)-one 
• 1390657-39-2 ethyl 2-((2-(tert-butoxycarbonyl)hydrazono)methyl)-4,6-dichloronicotinate 
• 1390657-38-1 ethyl-4,6-dichloro-2-formylnicotinate 
• 1390657-37-0 ethyl 2-(bromomethyl)-4,6-dichloronicotinate 
• 1390657-97-2 tert-butyl 4-(4-((2-chloro-5-oxo-5,6-dihydropyrido[2,3-d]pyridazin-4-yl)amino)-3-methoxyphenyl)piperidine-1-carboxylate 
• 307496-32-8 (2,5-difluorobenzyl)zinc (II) bromide 
• 1246533-06-1 tert-butyl 4-(4-amino-3-methoxy-phenyl)-3,6-dihydro-2H-pyridine-1-carboxylate 
• 1089280-53-4 tert-butyl 4-(4-amino-3-methoxyphenyl)piperidine-1-carboxylate 
• 3950-10-5 4,6-dihydroxy-2-methyl nicotinic acid ethyl ester 
• 686279-09-4 ethyl 4,6-dichloro-2-methylpyridine-3-carboxylate 
• 375853-82-0 tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-1(2H)-pyridinecarboxylate 

Relevant articles and documents

BICYCLIC INHIBITORS OF ALK

The present invention relates to compounds of formula (1) or pharmaceutical acceptable salts, wherein R1, X, Y, Z, A, B, G1, and n are defined in the description. The present invention relates also to compositions containing said compounds which are useful for inhibiting kinases such as ALK and methods of treating diseases such as cancer.